- Home
- PBYI
as 11-14-2025 3:42pm EST
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | LOS ANGELES |
| Market Cap: | 263.4M | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 635.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.74 | EPS Growth: | 59.87 |
| 52 Week Low/High: | $2.32 - $6.12 | Next Earning Date: | 11-06-2025 |
| Revenue: | $211,995,000 | Revenue Growth: | -12.96% |
| Revenue Growth (this year): | -4.18% | Revenue Growth (next year): | -4.39% |
Stock Insider Trading Activity of Puma Biotechnology Inc (PBYI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| MILLER MICHAEL PATRICK | PBYI | Director | Nov 11 '25 | Sell | $4.86 | 20,000 | $97,228.00 | 54,000 |
Latest Puma Biotechnology Inc News
PBYI Breaking Stock News: Dive into PBYI Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
Natural Health Trends And 2 Other Penny Stocks With Promising Financials
Simply Wall St.
a day ago
Alto Ingredients And 2 Other Penny Stocks To Watch Closely
Simply Wall St.
2 days ago
Top Penny Stocks To Watch In November 2025
Simply Wall St.
6 days ago
Puma Biotechnology, Inc. Just Beat EPS By 278%: Here's What Analysts Think Will Happen Next
Business Wire
8 days ago
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall St.
8 days ago
3 Promising Penny Stocks With Market Caps Below $600M
Zacks
8 days ago
PBYI's Q3 Earnings & Revenues Beat Estimates, 2025 Sales View Raised
Simply Wall St.
8 days ago
3 Penny Stocks Under $900M Market Cap Worth Watching
Compare PBYI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PBYI Puma Biotechnology Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.